Weight loss, during reduction

Weight loss during reduction corresponds to reduction of copper oxide to copper and decomposition of hydrates (1.7 wt%). 

A SETARAM TG 92 microbalance operated in flow mode with proximately 50 mg sample was used to follow the weight loss during the thermal treatment and temperature programmed reduction [5]. Flow type reactors and a 0.1-0.5 g sample were utilized for ... 

During these MNT educational and planning sessions, patients receive instructions on appropriate food selection, preparation, and proper portion control. The primary focus of MNT for patients with type 1 DM is matching optimal insulin dosing to carbohydrate consumption. In type 2 DM, the primary focus is calorie reduction to achieve weight loss. 

Antidepressants. Short-term studies of desipramine and fluoxetine indicate that both medications reduce binging in patients with BED. In addition, fluoxetine-treated patients may also experience a modest reduction in weight during short-term treatment. However, this early weight loss with fluoxetine may not be sustained despite continued treatment. 

Insomnia, decreased appetite, weight loss, dysphoria Possible reduction In growth velocity during long-term use Withdrawal and rebound hyperactivity Unmasking or induction of tics... 

Another amphetamine derivative, phentermine, has been in use as an appetite suppressant since its approval by the FDA in 1959. However, there are fewer clinical studies of phentermine s effectiveness in weight loss programs. Munro and colleagues (31) studied the effectiveness of phentermine during a 36-wk trial and reported a 13% reduction in initial body weight, compared to a 5.2% reduction for the placebo. The weight loss induced by phentermine over and above caloric restriction is comparable to that attained with fenfluramine. 

---